Brief: Roquefort Therapeutics Says Hy Net Loss Of £742,833

Coiled Therapeutics

27/09/2023 07:26

Sept 27 (Reuters) - Roquefort Therapeutics PLC  ROQ.L :
    * ON COURSE WITH TARGETS FOR CLINICAL READINESS FOR ONE OF
COMPANY'S DEVELOPMENT PROGRAMS DURING H2 2023
    * HY NET LOSS OF £742,833

Source text for Eikon:  ID:nRSa7420Na 
Further company coverage:  ROQ.L 

 ((Reuters.Briefs@thomsonreuters.com;))